Targeting the endocannabinoid system in cancer therapy: A call for further research
- 1 June 2002
- journal article
- review article
- Published by Springer Nature in Nature Medicine
- Vol. 8 (6), 547-550
- https://doi.org/10.1038/nm0602-547
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Review: cannabinoids control chemotherapy-induced nausea and vomiting but increase the risk of side effectsBMJ Evidence-Based Medicine, 2002
- Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematicBMJ, 2001
- Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent PathwayThe Journal of Immunology, 2000
- Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation1Endocrinology, 2000
- Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal periodSynapse, 1999
- ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevanceBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.Proceedings of the National Academy of Sciences, 1995
- The Effect of Marijuana Smoke Exposure on Murine Sarcoma 180 Survival in Fisher RatsImmunopharmacology and Immunotoxicology, 1989
- Antineoplastic Activity of Cannabinoids2JNCI Journal of the National Cancer Institute, 1975
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964